글로벌 진공 지원 생검 장치 시장 – 2030년까지의 산업 동향 및 예측

진공 지원 생검 장치 시장 분석 및 규모

생검은 장기에서 조직을 외과적으로 제거하는 데 사용되는 시술을 말합니다. 이 시술은 염증 및 암성 질환을 포함한 질병의 존재 또는 정도를 확인하기 위해 수행됩니다. 만성 질환의 유병률은 유방 생검 장치 시장의 성장을 가속화하고 있습니다.

Data Bridge Market Research는 2022년에 8억 1,185만 달러였던 글로벌 진공 보조 생검 장치 시장이 2030년까지 1,967.43만 달러에 도달할 가능성이 높으며 예측 기간 동안 11.70%의 CAGR을 기록할 것으로 분석했습니다. "진공 보조 생검 시스템"은 기술의 발전으로 인해 시장의 제품 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

진공 지원 생검 장치 시장 범위 및 세분화

시장 정의

Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyze in the laboratory for presence of a disease. Vacuum-assisted biopsy refers to a minimum insertion system that offers extraction of multiple tissue specimens.

Vacuum Assisted Biopsy Devices Market Dynamics

Drivers

• Increasing incidence of breast cancer

The rising prevalence of breast cancer across the globe is driving the demand for vacuum-assisted biopsy devices. These devices are widely used for the diagnosis and staging of breast cancer, leading to an increased adoption in the market.

• Advancements in biopsy techniques

Technological advancements in biopsy techniques, such as vacuum-assisted biopsy, have improved the accuracy and efficiency of the procedure. This has resulted in a higher demand for vacuum-assisted biopsy devices, as they offer better sampling and reduced procedure time compared to traditional biopsy methods.

• Growing preference for minimally invasive procedures

Vacuum-assisted biopsy devices are minimally invasive, allowing for faster recovery, reduced scarring, and lower risk of complications compared to open surgical biopsies. As a result, there is a growing preference for these devices among both patients and healthcare providers, driving market growth.

Opportunities

• Increasing awareness and screening programs

The rising awareness about the importance of early detection and screening for various types of cancers, including breast cancer, has led to an increase in screening programs. Vacuum-assisted biopsy devices play a crucial role in these programs by providing accurate and reliable biopsy samples, will expected to contributing to market growth.

• Favourable reimbursement policies

Favourable reimbursement policies for vacuum-assisted biopsy procedures in many countries have positively impacted the market. These policies ensure that patients have access to affordable and high-quality healthcare services, including biopsy procedures, will expected to contributing to market growth

• Technological advancements in imaging techniques

The integration of vacuum-assisted biopsy devices with advanced imaging techniques, such as ultrasound and MRI, has improved the accuracy and precision of biopsies. This has further will fueled the adoption of vacuum-assisted biopsy devices in the market.

 Restraints/Challenges

• High cost of devices

Vacuum-assisted biopsy devices can be expensive, which may limit their adoption, particularly in developing countries with limited healthcare budgets. The high cost of these devices can also pose a financial burden on healthcare facilities and patients, hindering market growth.

• Lack of skilled professionals

Performing a vacuum-assisted biopsy requires specialized training and expertise. However, there is a shortage of skilled professionals, such as radiologists and surgeons, who are proficient in using these devices. This can restrict the widespread adoption of vacuum-assisted biopsy devices and limit market growth.

This vacuum assisted biopsy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vacuum assisted biopsy devices market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2020, Hologic announced the launch of the Trident HD Specimen Radiography System, which is designed to enhance workflow and improve efficiency in breast-conserving surgeries and vacuum-assisted biopsies
• In February 2021, Medtronic announced the launch of the Achieve Advanced Enabling Technology for its Achieve Advanced Steerable Sheath. This technology provides enhanced control and access during vacuum-assisted biopsy procedures
• In 2019, Bard launched the EnCor Enspire Breast Biopsy System, which is a vacuum-assisted biopsy device designed to improve sample quality and streamline the biopsy process

Global Vacuum Assisted Biopsy Devices Market Scope

The vacuum assisted biopsy devices market is segmented on the basis product, type, technique, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Vacuum-Assisted Biopsy Systems
• Vacuum-Assisted Biopsy Needles

Type

• 9-12G
• <9G
• >12G

Technique

• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• MRI-Guided Biopsy
• Others

Applications

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

End User

• Hospitals
• Academic And Research Institutes
• Diagnostic And Imaging Centers
• Others

Vacuum Assisted Biopsy Devices Market Regional Analysis/Insights

The vacuum-assisted biopsy devices market is analyZed and market size insights and trends are provided by country, product, type, technique, applications and end user as referenced above.

The countries covered in the market  report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to dominate the market due to the large availability of trained medical professionals and availability of well-developed infrastructure facilities within the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to the surge in disposable income and rise in patient awareness toward disease screening in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The vacuum assisted biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for   vacuum assisted biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vacuum assisted biopsy devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Vacuum Assisted Biopsy Devices Market Share Analysis

The vacuum assisted biopsy devices market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. the above data points provided are only related to the companies' focus related to vacuum assisted biopsy devices market.

Some of the major players operating in the vacuum assisted biopsy devices market are:

• BD (U.S.)
• Cook (U.S.)
• Devicor Medical Products, Inc. (U.S.)
• ARGON MEDICAL. (U.S.)
• B. Braun Melsungen AG (Germany)
• Cardinal Health. (U.S.)
• Olympus Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• FUJIFILM Corporation (Japan)
• INRAD Inc. (U.S.)
• Medtronic (Ireland)
• 홀로직 주식회사(미국)

SKU-52678